Phillips Jack 4
4 · Accelerate Diagnostics, Inc · Filed Feb 2, 2024
Insider Transaction Report
Form 4
Phillips Jack
DirectorChief Executive Officer
Transactions
- Exercise/Conversion
Common Stock
2024-02-01+1,000→ 77,201 total - Sale
Common Stock
2024-02-01$1.30/sh−494$642→ 76,707 total - Exercise/Conversion
Employee Restricted Stock Units
2024-02-01−1,000→ 1,000 total→ Common Stock (1,000 underlying)
Footnotes (2)
- [F1]The reporting person was granted restricted stock units ("RSUs"), which represent a contingent right to receive one share of the issuer's common stock for each RSU upon vesting. On February 1, 2020, the reporting person was granted a total of 5,000 RSUs, which vest in equal annual amounts on each anniversary of the grant date over five years, beginning on February 1, 2021 and ending on February 1, 2025.
- [F2]The sale reported on this Form 4 represents shares sold by the reporting person to cover tax withholding obligations in connection with the vesting and settlement of RSUs. The sale was to satisfy tax withholding obligations to be funded by a "sell to cover" transaction and does not represent a discretionary transaction by the reporting person.